SLC7A11 and breast cancer: Although previous reports have indicated that xCT depletion in tumor cells leads to impaired tumor growth in vivo [18], our data obtained in mammary cancer-prone BALB-neuT mice show that congenital, total body xCT deficiency does not affect the time of onset or the multiplicity of tumors, but reduces the incidence of lung metastases.